H Lundbeck Extends Rave EDC, CDM Agreement With Medidata Solutions
Medidata Solutions said that Rave was selected by H Lundbeck initially in 2007 as an EDC system based on its ability to handle large and complex studies and

Medidata Solutions said that Rave was selected by H Lundbeck initially in 2007 as an EDC system based on its ability to handle large and complex studies and

AstraZeneca stated that the review by the advisory committee, part of the FDA’s evaluation of the new drug application (NDA) submitted for Ticagrelor, is based on the results

Bruker has posted a net income of $22.6m for the second quarter 2010, or $0.14 per diluted share, compared to net income of $12.9, or $0.08 per diluted

Under the terms of merger agreement, diaDexus expects to operate as a wholly-owned subsidiary of VaxGen. VaxGen has issued approximately 19,960,534 shares to certain diaDexus stockholders and officers,

As per the terms of the extended agreement, Regeneron Pharma is expected to receive $165m upfront and another $130m in June 2018 from Astellas, unless it terminates the

With the approval, Quest Diagnostics offers the test to physicians in New York as well as in all other US states. Quest Diagnostics said that the physicians can

Dr Mackenzie brings to CMPT a long record of executive board level management within the biotechnology and pharmaceutical industries at companies including Cambridge Genetics Ltd, Oxford Biomedica plc

PDL BioPharma has posted a net income of $50.1m for the second quarter 2010, or $0.30 per diluted share, compared to net income of $77.2m, or $0.47 per

Sildenafil is an active ingredient of an FDA-approved drug for male Erectile Dysfunction (ED). FDA said that the undeclared ingredient may interact with nitrates found in some prescription

Amarantus claimed that MANF is a highly potent, neurotrophic factor currently in pre-clinical development for the treatment of a range of diseases that includes Parkinson’s disease. Amarantus said